PDF - 4.73MB - Australian Sports Anti-Doping Authority

OVERVIEWThe Australian Sports Drug Medical Advisory Committee (ASDMAC) was established under section 52 of the AustralianSports Anti-Doping Authority Act 2006 (the ASADA Act) and clause 5 of the National Anti-Doping (NAD) scheme.ASDMAC performs its functions in accordance with the World Anti-Doping Code (the Code), the InternationalStandard for Therapeutic Use Exemptions (TUEs), the ASADA Act and the NAD scheme.During the year, Dr Hugh Hazard, an inaugural member of ASDMAC retired and Dr Terry Farquharson left theCommittee. Their replacements were Dr Carolyn Broderick and Dr Andrew Potter.ASDMAC held four meetings and processed 337 TUE applications in 2012–13.FUNCTIONSClause 5.01 NAD scheme — functions of ASDMACUnder the NAD scheme, ASDMAC’s functions are as follows:> ASDMAC may give an athlete approval, in accordance with the Code and the International Standard for TUEs,to use a prohibited substance or a prohibited method for therapeutic purposes.> ASDMAC may develop and implement its own procedure for the issuing of TUEs in accordance with theInternational Standard for TUEs.> If an athlete has an approval for the use of a prohibited substance or a prohibited method for therapeuticpurposes, ASDMAC may investigate the sample analysis result for a sample given by the athlete to find outwhether the athlete has complied with the conditions of the approval.> ASDMAC may investigate an atypical finding or an adverse analytical finding for a sample given by an athlete tofind out whether the atypical finding or adverse analytical finding was caused by naturally occurring levels of thesubstance concerned.> ASDMAC may review the procedures adopted by a sporting administration body for approving the use of aprohibited substance or a prohibited method.> ASDMAC may provide advice relating to TUEs and ASDMAC functions to ASADA, sporting administrationbodies, participants or other TUE committees.> If ASADA consults with ASDMAC about whether an approval for the use of a prohibited substance or aprohibited method for therapeutic purposes was given:• by ASDMAC, or• by a TUE committee, or• because of a decision by the World Anti-Doping Agency (WADA) following a review or appeal, ASDMAC mayinvestigate the approval and give its opinion to ASADA.> ASDMAC may participate in a review or an appeal that is related directly or indirectly to a decision made byASDMAC to:• approve the use of a prohibited substance or a prohibited method for therapeutic purposes, or• refuse to approve the use of a prohibited substance or a prohibited method for therapeutic purposes.138